R F Potter1, M A Wallace2, A R McMullen2, J Prusa3, C L Stallings3, C A D Burnham4, G Dantas5. 1. The Edison Family Center for Genome Sciences and Systems Biology, Washington University in St Louis School of Medicine, St Louis, MO, USA. 2. Department of Pathology and Immunology, Washington University in St Louis School of Medicine, St Louis, MO, USA. 3. Department of Molecular Microbiology, Washington University in St Louis School of Medicine, St Louis, MO, USA. 4. Department of Pathology and Immunology, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Molecular Microbiology, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Pediatrics, St Louis Children's Hospital, St Louis, MO, USA. Electronic address: cburnham@wustl.edu. 5. The Edison Family Center for Genome Sciences and Systems Biology, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Pathology and Immunology, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Molecular Microbiology, Washington University in St Louis School of Medicine, St Louis, MO, USA; Department of Biomedical Engineering, Washington University in St Louis, St Louis, MO, USA. Electronic address: dantas@wustl.edu.
Abstract
OBJECTIVES: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. METHODS: In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby-Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NextSeq platform. RESULTS: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. CONCLUSION: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.
OBJECTIVES: A carbapenem-resistant Providencia rettgeri (PR1) isolate was recovered from a wound infection in Missouri, USA. This isolate possessed an EDTA-inhibitable carbapenemase that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate the molecular determinant of carbapenem resistance in this isolate. We then sought to test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis isolates. METHODS: In October 2016 the novel ambler Class B carbapenemaseblaIMP-27, was reported in two different Proteus mirabilis (PM185 and PM187) isolates. Broth mating assays for transfer of carbapenemase activity were performed for the three clinical isolates with recipient sodium azide-resistant Escherichia coli J53. Antibiotic susceptibility testing and phenotypic carbapenemase activity testing were performed on the clinical isolates, J53 and transconjugants using the Kirby-Bauer disc diffusion method according to CLSI guidelines. Plasmid DNA from PM187, PR1 and their transconjugants were used as input for Nextera Illumina sequencing libraries and sequenced on a NextSeq platform. RESULTS: PR1 was resistant to both imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli through plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion system whereas pPR1 had a traB/traD type IV secretion system. CONCLUSION: Two of three blaIMP-27-bearing clinical isolates tested could conjugate resistance into E. coli. The resulting transconjugants became positive for phenotypic carbapenemase production but did not pass clinical resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types that rely on distinct classes of type IV secretion system for horizontal transfer.
Authors: Dixie F Mollenkopf; Jason W Stull; Dimitria A Mathys; Andrew S Bowman; Sydnee M Feicht; Susan V Grooters; Joshua B Daniels; Thomas E Wittum Journal: Antimicrob Agents Chemother Date: 2017-01-24 Impact factor: 5.191
Authors: Melanie M Pearson; Mohammed Sebaihia; Carol Churcher; Michael A Quail; Aswin S Seshasayee; Nicholas M Luscombe; Zahra Abdellah; Claire Arrosmith; Becky Atkin; Tracey Chillingworth; Heidi Hauser; Kay Jagels; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Danielle Walker; Sally Whithead; Nicholas R Thomson; Philip N Rather; Julian Parkhill; Harry L T Mobley Journal: J Bacteriol Date: 2008-03-28 Impact factor: 3.490
Authors: L F Mataseje; D A Boyd; B Lefebvre; E Bryce; J Embree; D Gravel; K Katz; P Kibsey; M Kuhn; J Langley; R Mitchell; D Roscoe; A Simor; G Taylor; E Thomas; N Turgeon; M R Mulvey Journal: J Antimicrob Chemother Date: 2013-11-24 Impact factor: 5.790
Authors: Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen Journal: J Antimicrob Chemother Date: 2012-07-10 Impact factor: 5.790
Authors: Luke Diorio-Toth; Sidra Irum; Robert F Potter; Meghan A Wallace; Muhammad Arslan; Tehmina Munir; Saadia Andleeb; Carey-Ann D Burnham; Gautam Dantas Journal: Microbiol Spectr Date: 2022-05-31
Authors: Alicia Shugart; Garrett Mahon; Jennifer Y Huang; Maria Karlsson; Ann Valley; Megan Lasure; Annastasia Gross; Brittany Pattee; Elisabeth Vaeth; Richard Brooks; Tyler Maruca; Catherine E Dominguez; David Torpey; Drew Francis; Rachana Bhattarai; Marion A Kainer; Allison Chan; Heather Dubendris; Shermalyn R Greene; Sara J Blosser; D J Shannon; Kelly Jones; Brenda Brennan; Sopheay Hun; Marisa D'Angeli; Caitlin N Murphy; Maureen Tierney; Natashia Reese; Amelia Bhatnagar; Alex Kallen; Allison C Brown; Maroya Spalding Walters Journal: JAC Antimicrob Resist Date: 2021-09-04
Authors: David A Boyd; Laura F Mataseje; Tanis Dingle; Linda Hoang; Brigitte Lefebvre; Allison McGeer; Roberto G Melano; Ian Stuart; Andrew Walkty; Amanda Wilmer; Michael R Mulvey Journal: mSphere Date: 2021-05-19 Impact factor: 4.389
Authors: Muhammad Rafique; Robert F Potter; Aura Ferreiro; Meghan A Wallace; Abdul Rahim; Akbar Ali Malik; Naila Siddique; Muhammad Athar Abbas; Alaric W D'Souza; Carey-Ann D Burnham; Naeem Ali; Gautam Dantas Journal: Front Microbiol Date: 2020-01-17 Impact factor: 5.640